» Articles » PMID: 26332144

Methods to Estimate the Between-study Variance and Its Uncertainty in Meta-analysis

Overview
Date 2015 Sep 3
PMID 26332144
Citations 420
Authors
Affiliations
Soon will be listed here.
Abstract

Meta-analyses are typically used to estimate the overall/mean of an outcome of interest. However, inference about between-study variability, which is typically modelled using a between-study variance parameter, is usually an additional aim. The DerSimonian and Laird method, currently widely used by default to estimate the between-study variance, has been long challenged. Our aim is to identify known methods for estimation of the between-study variance and its corresponding uncertainty, and to summarise the simulation and empirical evidence that compares them. We identified 16 estimators for the between-study variance, seven methods to calculate confidence intervals, and several comparative studies. Simulation studies suggest that for both dichotomous and continuous data the estimator proposed by Paule and Mandel and for continuous data the restricted maximum likelihood estimator are better alternatives to estimate the between-study variance. Based on the scenarios and results presented in the published studies, we recommend the Q-profile method and the alternative approach based on a 'generalised Cochran between-study variance statistic' to compute corresponding confidence intervals around the resulting estimates. Our recommendations are based on a qualitative evaluation of the existing literature and expert consensus. Evidence-based recommendations require an extensive simulation study where all methods would be compared under the same scenarios.

Citing Articles

The Oncological Outcome of Postoperative Radiotherapy in Patients with Node-Negative Early-Stage (T1/T2/N0) Oral Squamous Cell Carcinoma and Perineural Invasion: A Meta-Analysis.

Rao K, Sreeram M, de Bree R, Mendenhall W, Strojan P, Stenman G Cancers (Basel). 2025; 17(5).

PMID: 40075709 PMC: 11899070. DOI: 10.3390/cancers17050862.


The Cardiotoxicity Risk of Immune Checkpoint Inhibitors Compared with Chemotherapy: A Systematic Review and Meta-analysis of Observational Studies.

Zheng Y, Liu Z, Chen D, Zhang J, Yuan M, Zhang Y Cardiovasc Toxicol. 2025; .

PMID: 40053271 DOI: 10.1007/s12012-025-09979-1.


Fixed-effect versus random-effect model in meta-analysis: How to decide?.

Maitra S Indian J Anaesth. 2025; 69(1):143-146.

PMID: 40046706 PMC: 11878354. DOI: 10.4103/ija.ija_1203_24.


Fecal Microbiota Transplantation (FMT) and Clinical Outcomes Among Inflammatory Bowel Disease (IBD) Patients: An Umbrella Review.

Malik S, Naqvi S, Shadali A, Khan H, Christof M, Niu C Dig Dis Sci. 2025; .

PMID: 40038211 DOI: 10.1007/s10620-025-08946-8.


Application of oral nutritional supplements to control body weight loss in postoperative patients suffering from solid tumors: a systematic review and meta-analysis.

Liu Y, Wu Z, Shao T, Zheng W, Huang J Front Nutr. 2025; 12:1476463.

PMID: 40013158 PMC: 11860093. DOI: 10.3389/fnut.2025.1476463.


References
1.
DerSimonian R, Kacker R . Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2006; 28(2):105-14. DOI: 10.1016/j.cct.2006.04.004. View

2.
Turner R, Davey J, Clarke M, Thompson S, Higgins J . Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol. 2012; 41(3):818-27. PMC: 3396310. DOI: 10.1093/ije/dys041. View

3.
Kontopantelis E, Reeves D . Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation study. Stat Methods Med Res. 2010; 21(4):409-26. DOI: 10.1177/0962280210392008. View

4.
Biggerstaff B, Jackson D . The exact distribution of Cochran's heterogeneity statistic in one-way random effects meta-analysis. Stat Med. 2008; 27(29):6093-110. DOI: 10.1002/sim.3428. View

5.
Sidik K, Jonkman J . A comparison of heterogeneity variance estimators in combining results of studies. Stat Med. 2006; 26(9):1964-81. DOI: 10.1002/sim.2688. View